Skip to content
★ Sign in to follow
DC

Denise Connor

GlaxoSmithKline plc
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 11 Feb 2019 for GlaxoSmithKline plc.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Denise Connor: trading record in brief

This profile gathers the share dealings of Denise Connor in GlaxoSmithKline plc. Over a trading history stretching from 27 April 2018 to 8 February 2019, the count stands at 2 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 11 February 2019 came the latest disclosure, a transaction in GlaxoSmithKline plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Denise Connor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    PCA of Mr Roger Connor (President, Global Vaccines)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    6,000 sharesn/aISIN GB0009252882FCA-NSM:LSE20190211123855_13965116_20200326185110102_19467-0
  • ●
    PCA of Mr Roger Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    49,152 sharesn/aISIN GB0009252882FCA-NSM:LSE20180427124349_13622055_20200330111351032_1735-2

2 of 2 declarations